SEC Form 4 · accession 0001209191-15-045089
TALPHERA, INC. · TLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard B Rosen
Officer — Intermin CEO · Director
Period of report
May 19, 2015
Accepted (ET)
May 20, 2015 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001427925
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 19, 2015 | P$0 | 35,400 | — | A | 39,794 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were bought in multiple transactions at prices ranging from $3.27 to $3.36, inclusive. The reporting person undertakes to provide to Acelrx Pharmaceuticals, Inc., any security holder of Acelrx Pharmaceuticals, Inc., or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.